SCHEMBL6344006

SCHEMBL6344006

OC1(c2ccc(-c3ccccc3)cc2)CCCC1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 3/20 0.52
SLC6A4 P31645 3/20 0.52
SLC6A3 Q01959 3/20 0.52
OPRL1 P41146 4/20 0.46
OPRM1 P35372 3/20 0.46
OPRK1 P41145 3/20 0.46
DRD2 P14416 1/20 0.44
DRD4 P21917 1/20 0.44
DRD3 P35462 1/20 0.44
ALDH1A1 P00352 2/20 0.42
MAPT P10636 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
OPRD1 P41143 1/20 0.42
FASN P49327 1/20 0.41
CCR3 P51677 1/20 0.41
MMP3 P08254 1/20 0.41
BCL2L1 Q07817 1/20 0.41
AKR1C1 Q04828 1/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6348944 0.98 SLC6A2 (0.55) SLC6A2SLC6A4SLC6A3OPRL1OPRM1
SCHEMBL24845287 0.91 DRD2 (0.43) SLC6A2SLC6A4SLC6A3OPRL1OPRM1
SCHEMBL1109741 0.86 OPRL1 (0.57) OPRL1OPRM1OPRK1OPRD1AKR1C1
SCHEMBL4556223 0.84 OPRL1 (0.55) OPRL1OPRM1OPRK1OPRD1AKR1C1
SCHEMBL1040024 0.84 OPRL1 (0.55) OPRL1OPRM1OPRK1OPRD1AKR1C1
SCHEMBL16469256 0.84 OPRL1 (0.55) OPRL1OPRM1OPRK1OPRD1AKR1C1
Hydrogen Peroxide SCHEMBL14842577 0.84 OPRL1 (0.55) OPRL1OPRM1OPRK1OPRD1AKR1C1
SCHEMBL60129 0.84 OPRL1 (0.55) OPRL1OPRM1OPRK1OPRD1AKR1C1
SCHEMBL29195226 0.84 OPRL1 (0.55) OPRL1OPRM1OPRK1OPRD1AKR1C1
SCHEMBL1041473 0.84 OPRL1 (0.55) OPRL1OPRM1OPRK1OPRD1AKR1C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6900353-B2 Cyclopentyl sulfonamide derivatives ELI LILLY AND COMPANY (US) 2005-05-31 US disclosed
US-20040067984-A1 Cyclopentyl sulfonamide derivatives CANTRELL BUDDY EUGENE (US) 2004-04-08 US disclosed
EP-1334087-A1 CYCLOALKYLFLUOROSULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2003-08-13 EP disclosed
WO-2002032858-A1 CYCLOALKYLFLUOROSULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2002-04-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040067984-A1 Cyclopentyl sulfonamide derivatives GRIN2A, GRIN1, GRIK5 SLC6A2 136/4885SLC6A4 74/4885SLC6A3 73/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.